Angiotensin Receptor Neprilysin Inhibitor in Japanese Patients With Heart Failure and Reduced Ejection Fraction　― Baseline Characteristics and Treatment of PARALLEL-HF Trial ―-Reference-Cited by-同舟云学术

Angiotensin Receptor Neprilysin Inhibitor in Japanese Patients With Heart Failure and Reduced Ejection Fraction　― Baseline Characteristics and Treatment of PARALLEL-HF Trial ―

Published:2018-09-25 Issue:10 Volume:82 Page:2575-2583
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Tsutsui Hiroyuki¹,Momomura Shin-ichi²,Saito Yoshihiko³,Ito Hiroshi⁴,Yamamoto Kazuhiro⁵,Ohishi Tomomi⁶,Okino Naoko⁶,Kitamura Toshihito⁶,Guo Weinong⁷

Affiliation:

1. Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University

2. Cardiovascular Division, Jichi Medical University, Saitama Medical Center

3. First Department of Internal Medicine, Nara Medical University

4. Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

5. Department of Molecular Medicine and Therapeutics, Tottori University

6. Novartis Pharma K.K.

7. Novartis Pharmaceutical Corporation

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/82/10/82_CJ-17-1424/_pdf

Reference17 articles.

1. 1. Kitakaze M. Trends in characteristics of CVD in Asia and Japan: The importance of epidemiological studies and beyond. J Am Coll Cardiol 2015; 66: 196–198.

2. 2. Shimokawa H, Miura M, Nochioka K, Sakata Y. Heart failure as a general pandemic in Asia. Eur J Heart Fail 2015; 17: 884–892.

3. 3. World Health Organization. The global burden of disease: 2004 update. Geneva: WHO, 2008.

4. 4. McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014; 371: 993–1004.

5. 5. Packer M, McMurray JJ, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure. Circulation 2015; 131: 54–61.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Late Kidney Injury After Admission to Intensive Care Unit for Acute Heart Failure;International Heart Journal;2024-05-31

2. Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society;Journal of Cardiac Failure;2023-05

3. Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society;European Journal of Heart Failure;2023-04-26

4. Effect of sacubitril/valsartan on natriuretic peptide in patients with compensated heart failure;Heart and Vessels;2023-01-19

5. New paradigm shift in the pharmacotherapy for heart failure-where are we now and where are we heading?;Journal of Cardiology;2023-01